Felypressin acetate NEW
| Price | $39 | $64 | $128 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-06-02 |
Product Details
| Product Name: Felypressin acetate | CAS No.: 914453-97-7 |
| Purity: 97.06% | Supply Ability: 10g |
| Release date: 2026/06/02 |
Product Introduction
Bioactivity
| Name | Felypressin acetate |
| Description | Felypressin acetate (PLV-2) is an agonist of vasopressin 1 and acts on all arginine vasopressin receptors 1AS. Felypressin acetate can be used in dental procedures. |
| In vitro | Felypressin is a synthetic posterior pituitary hormone with vasoconstrictive properties mediated through V1 receptors in blood vessel smooth muscle cells[4]. |
| In vivo | In Wistar rats, Felypressin (240 ng/kg; i.v.) induces a pressor effect and bradycardic effect depending on V1 receptors to induce pressor and bradycardic effects. Felypressin produces a high relationship between bradycardia and mean arterial pressure vari |
| Storage | Keep away from moisture Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 125 mg/mL (113.61 mM), Sonication is recommended. 10% DMSO+90% Saline : 10 mg/mL (9.09 mM), Solution. |
| Keywords | VasopressinReceptor | Vasopressin receptor 1 | Vasopressin Receptor | Vasopressin 1 | vasoconstrictor | PLV2. H-Cys-Phe-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 | PLV2 | pituitary | non-catecholamine | Inhibitor | inhibit | hormone | Felypressin acetate | Felypressin | Disulfide bond | dental | Arginine | anesthetic |
| Inhibitors Related | Mozavaptan | Desmopressin acetate (16679-58-6 free base) | OPC-51803 | Nelivaptan | PF-184563 | Ornipressin Acetate(3397-23-7,free) | d[Leu4,Lys8]-VP acetate | E-4177 | Atosiban | Fuscoside | Tolvaptan | WAY-267464 |
| Related Compound Libraries | Macrocyclic Compound Library | Bioactive Compound Library | Cyclic Peptide Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Peptide Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP1Y
|
Jinan Ruitong Biotech Co., Ltd.
|
2026-06-08 | ||
| $60.00 |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2026-07-06 | |
|
VIP4Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2025-04-04 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY